Across cancer types
-
Neutropenic Diets: What the 2026 Evidence Does—and Does Not—Settle
A stopped trial and a September 2026 meta-analysis point to a more nuanced approach: food safety…
-
St. John’s Wort and Cancer Drugs: A Small Study With a Big Warning
A five-person irinotecan study found substantially lower exposure to its active metabolite with St. John’s wort.…
-
Massage for Pain in Advanced Cancer: Relief Matters, and So Does the Comparison
Oncology-adapted massage may help pain, but a three-point improvement is not automatically a three-point treatment effect.…
-
Early Palliative Care: More Support Alongside Cancer Treatment
Palliative care is not reserved for the last days of life. Trials in advanced lung cancer…
-
L-Carnitine for Cancer Fatigue: Why an Energy Nutrient Is Not an Energy Prescription
L-carnitine has a plausible role in energy metabolism, but its largest fatigue trial was negative. A…
-
Music Therapy for Cancer-Related Anxiety: What the MELODY Trial Adds
A 2026 trial compared therapist-led music therapy with cognitive behavioral therapy for anxiety in cancer survivors.…
-
Creatine During Cancer Care: Does the Muscle-Building Story Hold Up?
A 2026 review of five randomized trials found no clear benefit for lean mass, strength or…
-
Coenzyme Q10 for Cancer-Related Fatigue: A Plausible Idea Meets a Negative Trial
CoQ10 can improve fatigue in some noncancer settings, but the best direct breast-cancer trial found no…
-
Olanzapine for Appetite Loss During Chemotherapy: A Small Dose, a Striking Trial
A 124-person randomized trial found substantially more appetite improvement and weight gain with low-dose olanzapine during…
-
Exercise With Bone Metastases: Safer Than We Once Thought—When the Program Fits the Lesions
A randomized trial found that lesion-aware, supervised exercise improved strength and self-reported function without increasing fractures…
